Group 1 - The article discusses the challenges and humorous situations faced by parents in understanding their children's experiences and relationships [5][39]. - It highlights the importance of communication and emotional support between parents and children, emphasizing a caring and non-judgmental approach [39]. - The narrative includes various light-hearted anecdotes that reflect the complexities of parenting and the generational gap in understanding [11][30]. Group 2 - The article mentions the creative and imaginative aspects of children, showcasing their ability to think outside the box [25][48]. - It touches on the significance of maintaining a positive atmosphere in family interactions, particularly during challenging times [39]. - The content also reflects on the evolving dynamics of family relationships, where parents strive to adapt to their children's needs and preferences [39].

Core Insights - The Chinese cosmetics market is undergoing a significant paradigm shift, moving from "scale expansion" to "quality leadership" as it surpasses a market size of 1 trillion yuan and domestic brands exceed international ones in sales [1] - HBN, a skincare brand that has filed for an IPO in Hong Kong, exemplifies this shift by focusing on "slow research-driven efficacy," providing a model for domestic brands aiming for high-end market penetration [1] Group 1: Market Trends - The transition of domestic cosmetics brands to high-end positioning is a notable trend, involving upgrades in brand positioning, product efficacy, and consumer perception [4] - HBN has capitalized on the rise of ingredient-focused consumers and the popularization of scientific skincare, playing a dual role in market education and category definition [4] Group 2: HBN's Product Development - HBN has pioneered the "early C, late A" skincare formula, launching successful products like the dual retinol night cream and brightening water, establishing itself in the high-end retinol market [5] - The brand's retinol skincare products and α-arbutin essence have ranked first in national sales for three consecutive years from 2022 to 2024, with cumulative sales of over 30 million units by the end of 2025 [5] Group 3: Consumer Engagement - HBN has accumulated over 4.6 million high-repeat purchase users, with average transaction values gradually increasing; its repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively [7] Group 4: Research and Development - HBN's commitment to "slow research" has built a systematic innovation capability, driving the brand towards high-end positioning [8] - The company has established a complete research loop from basic research to raw material innovation and efficacy verification, with a research team of 103 professionals across various fields [8][10] - HBN has published over 50 international SCI papers, ranking first among domestic skincare brands in terms of publications as the first author [8] Group 5: Efficacy Verification and Industry Contribution - HBN has developed a comprehensive "full-link multi-dimensional cross-validation system" for product efficacy, being the only Chinese skincare brand to conduct efficacy testing through international authoritative institutions [10] - The brand is also advocating for the establishment of a scientific evaluation system for cosmetic efficacy evidence, marking its transition from a market participant to a contributor to high-quality industry development [10] - This shift signifies HBN's role in defining industry standards and its commitment to high-end brand development through continuous investment in research and innovation [10]

Core Viewpoint - HBN has established itself as a leading domestic skincare brand in China, particularly known for its effective retinol products and the "early C, late A" skincare philosophy, and is now seeking to go public on the Hong Kong Stock Exchange [1][3]. Group 1: Brand Development and Market Position - HBN was founded in 2019 and chose to focus on the challenging retinol market, which was dominated by international brands, by emphasizing ingredient transparency and authoritative evidence [3][4]. - The brand has successfully positioned itself in the market by introducing a comprehensive product line that includes retinol-based skincare products, achieving the highest sales in its category from 2022 to 2024 [4][6]. Group 2: Research and Development Strategy - HBN has invested heavily in R&D and established a comprehensive verification system to ensure that all product claims are backed by clinical data, making it the only Chinese skincare brand to conduct efficacy testing through international authorities [6][7]. - The company has developed a sustainable innovation system that allows for the efficient reuse of research outcomes, leading to the continuous launch of new products and categories [7][9]. Group 3: Financial Performance and User Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [10]. - Financially, HBN reported total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, and a 190.3% year-on-year increase in net profit for the first three quarters of 2025 [10].

Group 1 - The core viewpoint of the article highlights the milestone of Shenzhen reaching 600 listed companies, showcasing the strong capital vitality of the Shenzhen market, particularly in the hard technology sector [1] - HBN, a skincare brand focusing on efficacy, has submitted its listing application to the Hong Kong Stock Exchange, representing a new addition to Shenzhen's innovative landscape [1][10] - HBN's founder, Yao Zhenan, has a background in both technology and aesthetics, which has influenced the brand's commitment to genuine efficacy in skincare [3] Group 2 - HBN has established itself as a pioneer in the A-retinol anti-aging segment, with its products ranking first in sales within the category for three consecutive years from 2022 to 2024 [4] - The brand is recognized as the youngest among the top ten domestic skincare brands in China, and it leads the market for improvement-oriented skincare products [4] - HBN's research team consists of 103 members with expertise in various fields, contributing to its innovative product development and industry-leading results [6] Group 3 - HBN is the only skincare brand in China that has undergone efficacy testing by an international authority for its entire product line, reinforcing its commitment to genuine efficacy [8] - The brand has accumulated over 4.6 million repeat customers, with average repurchase rates on platforms like Tmall and Douyin significantly exceeding industry averages [8] - Financially, HBN achieved total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, indicating a healthy growth trajectory [9] Group 4 - HBN's upcoming listing on the Hong Kong Stock Exchange marks a new development phase, leveraging its commitment to rigorous research and user trust to set a differentiated path in the beauty and broader consumer sectors [10]

Core Viewpoint - HBN's parent company, Shenzhen Hujia Technology (Group) Co., Ltd., has submitted a listing application to the Hong Kong Stock Exchange, with Morgan Stanley and CICC as joint sponsors. The funds raised will primarily be used for R&D, product innovation, enhancing production capacity, improving office environments, and expanding digital operations and marketing efforts [1][14]. Financial Performance - In 2023, 2024, and the first three quarters of 2025, HBN achieved revenues of RMB 19.48 billion, RMB 20.8 billion, and RMB 15.14 billion, with year-on-year growth rates of 6.9% and 10.2% for 2024 and 2025, respectively. Net profits for the same periods were RMB 38.83 million, RMB 129.14 million, and RMB 144.53 million, reflecting significant growth of 232.5% and 190.3% in 2024 and 2025 [4][17]. Marketing and R&D Expenditure - Approximately 60% of HBN's revenue is allocated to marketing, while R&D investment remains low at around 3%, raising concerns about the sustainability of its business model. In 2023, 2024, and 2025, marketing expenses were RMB 12.68 billion, RMB 12.38 billion, and RMB 8.7 billion, accounting for 65.1%, 59.4%, and 57.6% of total revenue, respectively. In contrast, R&D expenditures were only RMB 0.66 billion, RMB 0.58 billion, and RMB 0.4 billion [6][21][22]. Product and Brand Dependency - HBN's product lines include both improvement and stabilization skincare products, with a total of 36 SKUs priced between RMB 129 and RMB 689. The company heavily relies on its single brand, HBN, for revenue generation, which poses risks if consumer preferences shift or if the brand faces reputational issues [4][10][17]. Sales Channel Concentration - HBN's sales are predominantly online, with online revenue accounting for 98.6%, 97.7%, and 95.1% in 2023, 2024, and 2025, respectively. In contrast, offline sales are minimal, representing only 1.4% and 2.3% of total revenue in 2023 and 2024. This heavy reliance on online channels may limit the company's ability to reach customers who prefer in-store experiences [11][24]. Industry Challenges - The skincare industry faces significant challenges, including product homogenization and intense price competition, which can undermine profitability. The heavy focus on marketing over R&D may hinder innovation and long-term growth, making companies vulnerable to market fluctuations and consumer trends [9][22].

Core Viewpoint - Shenzhen Hujia Technology (Group) Co., Ltd. has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with its brand HBN being a leading domestic skincare brand advocating the "early C, late A" skincare concept, and spending over 1 billion yuan annually on promotions [1][4]. Financial Performance - The company's revenue for the years 2023, 2024, and the first three quarters of 2025 were 1.948 billion yuan, 2.083 billion yuan, and 1.514 billion yuan respectively, with net profits of 39 million yuan, 129 million yuan, and 145 million yuan, and gross profit margins of 76.6%, 73.4%, and 75.3% [4]. - Revenue primarily comes from "improvement-type skincare products" and "stabilizing-type skincare products," with the former accounting for 78.3% to 81.8% of total revenue during the reporting period [4]. Business Model - The company heavily relies on a single brand, HBN, with its core growth driven by the market performance of concepts like "early C, late A" [4]. - Online sales channels accounted for 98.6%, 98.7%, and 95.1% of total sales during the reporting periods, indicating a strong dependence on e-commerce [4]. Inventory Management - The company's inventory at the end of each reporting period was 140 million yuan, 178 million yuan, and 180 million yuan, with inventory turnover days increasing from 113 days to 130 days, showing a significant upward trend [4]. Marketing and Promotion - Sales and distribution expenses were 1.268 billion yuan, 1.238 billion yuan, and 871 million yuan, representing 65.1%, 59.4%, and 57.6% of total revenue during the respective periods [7]. - The company emphasizes the need for effective brand, market, and marketing strategies to attract and retain consumers, leveraging social media and KOLs for promotion [7]. Shareholding Structure - The founder, Yao Zhenan, and his wife control 76.19% of the voting rights in the company, with Yao holding 35.08% directly and an additional 19.51% through proxy arrangements [9][11]. - The company declared a cash dividend of 100 million yuan prior to its listing application, with nearly 50 million yuan expected to benefit the controlling couple [11] Use of Proceeds - The funds raised from the listing will be used for R&D and product innovation, enhancing production capacity, improving office environments, boosting digital operations, investing in brand and market promotion, and general corporate purposes [12].

Core Viewpoint - HBN, a domestic skincare brand, has gained significant popularity among young consumers with its "early C, late A" concept and is preparing for an IPO to become the first publicly listed company in the domestic efficacy skincare sector, although it faces challenges related to high marketing costs and low R&D investment [1][2][4]. Company Performance - Shenzhen Hujia Technology (Group) Co., Ltd., the parent company of HBN, reported revenues of 1.948 billion yuan, 2.083 billion yuan, and 1.514 billion yuan for the years 2023, 2024, and the first nine months of 2025, respectively, with a year-on-year growth of 6.9% in 2024 and an increase of 10.2% in the first nine months of 2025 [2]. - The net profit showed explosive growth, with figures of 38.835 million yuan, 129 million yuan, and 145 million yuan for the same periods, reflecting a year-on-year increase of 232.5% in 2024 and a 190.3% increase in the first nine months of 2025 compared to the entire year of 2024 [2]. Market Position - The Chinese dermatological skincare market is experiencing a compound annual growth rate (CAGR) of 16.7% from 2019 to 2024, significantly outpacing the overall skincare market growth of approximately 8.6% [4]. - HBN ranks first among domestic brands in both improvement skincare products and dermatological skincare segments, with its core product "glow water" consistently leading the domestic essence water category [4]. Customer Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of 35.4% on Tmall and 44% on Douyin, indicating strong customer loyalty [4]. Marketing and Sales Expenses - Hujia Technology's sales and distribution expenses have been rising, with figures of 1.267 billion yuan, 1.238 billion yuan, and 871 million yuan for 2023, 2024, and the first three quarters of 2025, respectively, accounting for 65.1%, 59.4%, and 57.6% of total revenue [4][6]. - Promotion expenses, which include advertising on e-commerce platforms and KOL/KOC fees, are the largest expenditure, amounting to approximately 1.048 billion yuan, 721 million yuan, and 720 million yuan during the same periods, representing 57.2%, 50.4%, and 47.6% of total revenue [6]. R&D and Product Complaints - Despite its strong market performance, Hujia Technology's R&D investment is relatively low, with R&D expenses of 65.979 million yuan, 57.834 million yuan, and 39.981 million yuan, leading to a decline in R&D expense ratio from 3.4% to 2.64%, which is below the industry average [10]. - The company has faced consumer complaints, with 948 reported cases on Black Cat Complaints, primarily concerning false advertising and allergic reactions, raising concerns about its "allergy-free guarantee" service [11][15]. Founder's Background and Shareholder Structure - The founder, Yao Zhenan, transitioned from academia to entrepreneurship, initially launching a sanitary napkin brand before entering the skincare market with HBN in 2019, focusing on anti-aging products [16][18]. - Meitu, the largest external shareholder, holds a 23.81% stake in Hujia Technology, and the company has announced a cash dividend plan of 100 million yuan ahead of its IPO [19][21].

Core Viewpoint - HBN, a rising skincare brand in China, is preparing for an IPO on the Hong Kong Stock Exchange, aiming to capitalize on the growing trend of domestic consumer brands going public [1][2]. Company Overview - HBN, founded in 2019, focuses on effective skincare products, particularly promoting the "Morning C, Evening A" concept, which emphasizes using vitamin C in the morning and retinol at night [2][4]. - The brand has quickly gained popularity, becoming one of the youngest brands in the top ten domestic skincare market, achieving significant sales growth within a short period [1][4]. Financial Performance - HBN's revenue reached approximately 19.48 billion RMB in 2023, with projections of 20.8 billion RMB in 2024 and 15.14 billion RMB for the first three quarters of 2025 [8]. - The net profit for the same periods was 38.8 million RMB, 129 million RMB, and 145 million RMB, indicating a substantial increase in net profit margin from 1.9% to 9.6% [8]. - The brand's average repurchase rates on platforms like Tmall and Douyin are around 35.4% and 44.0%, respectively, with over 4.6 million cumulative repurchase users [8]. Product and Market Position - HBN's product lines include anti-aging and daily skincare products, with prices ranging from 129 RMB to 689 RMB [6]. - The brand is ranked fourth among domestic mid-to-high-end skincare brands and is the largest domestic brand in the improvement skincare segment [8]. Business Structure and Risks - HBN's revenue is heavily reliant on a few key products, which accounted for nearly 40% of sales, raising concerns about business sustainability [9]. - The company has a high concentration of online sales, with online revenue accounting for over 95% in recent years, indicating limited diversification in sales channels [9][10]. Investment and Shareholding - Prior to the IPO, HBN's founders held a combined 76.19% voting power, with significant external investment from Meitu, which holds 23.81% of the shares [5]. - The company recently declared a cash dividend of 100 million RMB, with a portion already paid out, benefiting the founders significantly [5]. Industry Context - The trend of consumer brands going public in Hong Kong is accelerating, with numerous companies filing for IPOs, indicating a competitive environment for HBN [12][13]. - The Hong Kong Stock Exchange is experiencing a surge in IPO applications, with over 350 companies in the queue, highlighting the urgency for HBN to finalize its listing [16].

Core Viewpoint - HBN, a rising skincare brand in China, is preparing for an IPO on the Hong Kong Stock Exchange, aiming to capitalize on the current trend of domestic consumer brands going public [4][5]. Company Overview - HBN's parent company, Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application, with Morgan Stanley and CICC as joint sponsors [4]. - Founded by a couple from Guangdong, HBN has quickly gained popularity in the skincare market, particularly with its "Morning C, Evening A" skincare philosophy [5][7]. - The brand has achieved significant revenue growth, entering the 2 billion to 4 billion RMB revenue tier within four years of its establishment [7][12]. Financial Performance - HBN's revenue for the first three quarters of 2023, 2024, and 2025 was 1.948 billion, 2.082 billion, and 1.373 billion RMB respectively, with net profits of 38.8 million, 129 million, and 145 million RMB, showing a net profit margin increase from 1.9% to 9.6% [12][14]. - The brand's product lines include both improvement-type and maintenance-type skincare products, with the former accounting for approximately 80% of revenue [12][13]. Market Position - HBN ranks fourth among domestic mid-to-high-end skincare brands in China, and it is the largest domestic brand in the improvement-type skincare market [12]. - The brand's average repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively, indicating strong customer loyalty [12]. Business Structure and Risks - HBN's revenue is heavily reliant on a few key products, which accounted for nearly 40% of sales, raising concerns about business vulnerability [13]. - The company's sales channels are predominantly online, with online revenue accounting for over 95% in recent years, while offline revenue remains below 1 billion RMB [13][14]. - Marketing expenses are high, with over 50% of revenue spent on marketing, while R&D investment has decreased, leading to questions about the sustainability of its competitive edge [14][15]. Industry Context - The current IPO climate in Hong Kong is competitive, with many consumer brands rushing to list, reflecting a broader trend of domestic companies seeking capital through public offerings [16][18]. - The Hong Kong Stock Exchange has over 350 companies in the IPO pipeline, indicating a robust interest in market entry despite regulatory challenges [18].

Core Viewpoint - The Chinese skincare brand HBN, under Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application to the Hong Kong Stock Exchange, highlighting a growth model driven by deep research and rigorous validation, transitioning from "ingredient claims" to "evidence-based support" [1] Group 1: Research-Driven Innovation - HBN was founded in 2019 with the brand philosophy of "making true efficacy a reality," adhering to a long-term development path of "slow research" [4] - As of September 30, 2025, HBN's R&D team will consist of 103 members with diverse backgrounds in dermatology, medicine, cell biology, and synthetic biology, showcasing interdisciplinary collaboration [5] - HBN ranks third among domestic brands in the number of new cosmetic ingredients registered as of September 2025, indicating innovation extending from product formulation to the source ingredient [7] Group 2: Market Position and Product Innovation - HBN has become the youngest brand among the top ten domestic skincare brands in China, leading the market in the segment of improvement skincare products [7] - HBN's A-alcohol skincare products and α-arbutin essence have ranked first in sales within their category for three consecutive years (2022-2024), establishing a clear category advantage [7] Group 3: Building User Trust and Business Health - HBN has developed a comprehensive "full-link multi-dimensional verification system," recognized as the only skincare brand in China to conduct efficacy testing on all products through international authoritative testing agencies [8] - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [9] - In 2024, HBN achieved total revenue of 2.083 billion yuan and a net profit of 129 million yuan, with a net profit margin increasing from 3.5% to 9.6% in the first three quarters of 2025 [9] Group 4: Strategic Significance of IPO - HBN's IPO in Hong Kong marks a critical milestone in its development model of "research-driven innovation and evidence-based trust building," providing a reference for domestic brands to achieve sustainable growth in a competitive market [11]